Hui Liang
Impact in
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
-
- RNA modifications and cancer 6
- Gut microbiota and health 4
-
- Kidney Stones and Urolithiasis Treatments 9
- Ferroptosis and cancer prognosis 4
- Co-authors
- Zhu Wang (28 shared papers)Jianwen Zhang (11 shared papers)Qiong Deng (8 shared papers)Ying Zhang (3 shared papers)Qiong Deng (19 shared papers)Shengping Zhang (4 shared papers)Huang Yi (1 shared paper)Fang He (1 shared paper)
- Journals
- Artificial Cells Nanomedicine and Biotechnology (4 papers)Cellular Physiology and Biochemistry (3 papers)BMC Urology (3 papers)Physical review. B. (2 papers)International Journal of Molecular Medicine (2 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Hui Liang
135 papers receiving 1.9k citations
Hui Liang's Hit Papers
Peers
Comparison fields: 5 of 146
- Molecular Medicine 192
- Cancer Research 237
- Hepatology 120
- Endocrinology 85
- Pulmonary and Respiratory Medicine 372
Countries citing papers authored by Hui Liang
This map shows the geographic impact of Hui Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui Liang more than expected).
Fields of papers citing papers by Hui Liang
This network shows the impact of papers produced by Hui Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui Liang. The network helps show where Hui Liang may publish in the future.
Co-authors
The 25 scholars most cited alongside Hui Liang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 151 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Recent advances on the mechanisms of kidney stone formation (Review) Hit paper breakdown → | 2021 | 170 |
| 2 | 2012 | 108 | |
| 3 | 2007 | 85 | |
| 4 | 2017 | 79 | |
| 5 | 2021 | 76 | |
| 6 | 2019 | 67 | |
| 7 | 2015 | 60 | |
| 8 | 2014 | 58 | |
| 9 | 2020 | 54 | |
| 10 | 2022 | 48 | |
| 11 | 2010 | 45 | |
| 12 | 2020 | 41 | |
| 13 | 2017 | 38 | |
| 14 | 2015 | 38 | |
| 15 | 2007 | 37 | |
| 16 | 2019 | 34 | |
| 17 | 2011 | 32 | |
| 18 | 2014 | 32 | |
| 19 | 2018 | 30 | |
| 20 | 2023 | 29 |
About Hui Liang
Hui Liang is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Oncology, Cancer Research and Immunology, having authored 151 papers that have together received 2.0k indexed citations. Recurring topics across this work include Kidney Stones and Urolithiasis Treatments (9 papers), Cancer-related molecular mechanisms research (8 papers), MicroRNA in disease regulation (7 papers), RNA modifications and cancer (6 papers), Cancer Immunotherapy and Biomarkers (5 papers), Gut microbiota and health (4 papers), Antibiotic Resistance in Bacteria (4 papers) and Ferroptosis and cancer prognosis (4 papers). The work is most often cited by research in Molecular Medicine (192 citations), Cancer Research (237 citations), Hepatology (120 citations), Endocrinology (85 citations) and Pulmonary and Respiratory Medicine (372 citations). Hui Liang has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Zhu Wang, Jianwen Zhang, Qiong Deng, Ying Zhang, Qiong Deng, Shengping Zhang, Huang Yi, Fang He, Y. Z. Wan and Zhenwei Peng. Their work appears in journals such as Artificial Cells Nanomedicine and Biotechnology, Cellular Physiology and Biochemistry, BMC Urology, Physical review. B. and International Journal of Molecular Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.